List of Excipients in API dabigatran etexilate mesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dabigatran etexilate mesylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | ACACIA | |
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | ALCOHOL | |
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | BUTYL ALCOHOL | |
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | CARRAGEENAN | |
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | DIMETHICONE | |
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | FD&C BLUE NO. 2 | |
| Rebel Distributors Corp | PRADAXA | dabigatran etexilate mesylate | 21695-899 | FD&C YELLOW NO. 6 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for dabigatran etexilate mesylate
Excipient focus: ACACIA
dabigatran etexilate mesylate drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
dabigatran etexilate mesylate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
dabigatran etexilate mesylate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
dabigatran etexilate mesylate drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
dabigatran etexilate mesylate drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
dabigatran etexilate mesylate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
dabigatran etexilate mesylate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
dabigatran etexilate mesylate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
dabigatran etexilate mesylate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
dabigatran etexilate mesylate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
dabigatran etexilate mesylate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
dabigatran etexilate mesylate drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
dabigatran etexilate mesylate drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
dabigatran etexilate mesylate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
dabigatran etexilate mesylate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
dabigatran etexilate mesylate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
dabigatran etexilate mesylate drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dabigatran etexilate mesylate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dabigatran etexilate mesylate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate mesylate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links